Login / Signup

Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study.

Jacob TønnesenJannik PallisgaardPeter Vibe RasmussenMartin Huth RuwaldMorten LambertsNina NouhraveshJarl StrangeGunnar Hilmar GislasonMorten Lock Hansen
Published in: BMJ open (2023)
We found that most VTE events happen close to onset of the GI cancer diagnosis and thrombogenicity differed by type of GI cancer, ranging from 7.8% in patients with pancreatic cancer to 3.6% in colorectal and patients with liver cancer. Prior VTE, heart failure, COPD, liver disease, CKD and DM were associated with increased risk of VTE.
Keyphrases